Fabienne Portales

2PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 17, 2025
GABRINOX-2 protocol: a French, prospective, multicentre, randomised phase II trial evaluating gemcitabine/nab-paclitaxel followed by FOLFIRINOX versus FOLFIRINOX alone as first-line treatment for metastatic pancreatic cancer.

Fabienne Portales, Sophie Gourgou, Catherine Fiess

|Jun 21, 2025
Regorafenib plus modified gemcitabine-oxaliplatin in patients with advanced biliary tract cancer. The randomized phase Ib/II BREGO study.

Jean-Frédéric Blanc, Mohamed Bouattour, Ludovic Gauthier

Pageof 1

Frequent Collaborators

1 joint publications

Jean-Frédéric Blanc

1 joint publications

Mohamed Bouattour

1 joint publications

Emmanuel Deshayes

1 joint publications

Sophie Guillemard